You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers were able to differentiate among patients with lung cancer, COPD, and health controls using the biomarkers.
The results could inform diagnosis and treatment for PTSD and PTSD-associated and inflammation-associated disorders.
UK-based XRGenomics is using Affymetrix's GeneTitan platform to develop a gene expression signature as a stratification tool for dementia research.
Prices in Germany for noninvasive prenatal testing have plummeted over the last year, driven by competition and process improvements.
Athletigen will use the Axiom genotyping platform to process its microarrays analyzing 850,000 genetic variants that could be related to sports performance.
CDI Laboratories will use Arrayjet's Ultra Marathon II instrument to print its proteomics and other custom microarrays.
The researchers identified a large set of potential markers, and then narrowed them down to those with the most practical diagnostic potential.
Though differing in their coverage breadth and targets, the researchers found the methods to be highly concordant.
Researchers from the University of Washington and elsewhere scrutinized duplication and deletion profiles in individuals from 125 human populations.
The firm set multiple records for testing volume and revenues as it grew both its sales team and customer base during the quarter.
NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.
Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.
A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.
In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.